©2018 by Canadian Association of Veterinary Cannabinoid Medicine. Proudly created with Wix.com

ONCOLOGY

Frontiers | Cannabis Therapeutics and the Future of Neurology | Frontiers in Integrative Neuroscience

 

GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine | Oncogene

 

Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients


 

Frontiers | Cannabis sativa: The Plant of the Thousand and One Molecules | Plant Science

 

Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation. - PubMed - NCBI

 

IJMS | Free Full-Text | Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells

 

Rates of cannabis use in patients with cancer. - PubMed - NCBI

 

Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression

 

Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene, isocaryophyllene and paclitaxel. - PubMed - NCBI

 

Integrating cannabis into clinical cancer care

 

Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol. - PubMed - NCBI

 

Endocannabinoids and Cancer

 

Studies on CBD and Cancer

 

Cannabis and Cannabinoids (PDQ®)—Health Professional Version - National Cancer Institute

 

Practical considerations in medical cannabis administration and dosing - European Journal of Internal Medicine